oral semaglutide 50 mg oasis 1 nejm 2023 obesity 🚨 25 delivers double-digit weight loss in OASIS-4 (Phase 3 trial) - Study reveals oral Semaglutide 50

Garca-Compen D, Gonzlez-Gonzlez JA, Lavalle-Gonzlez FJ, Gonzlez-Moreno EI, Maldonado-Garza HJ, Villarreal-Prez JZ

General discomfort in the hand, wrist, or fingers, along with difficulties in gripping or holding objects, are also symptoms

However, indirect effects of rapid weight lossincluding muscle loss, dehydration, and postural changescan trigger or worsen existing back pain in some patients

As these drugs gain notoriety because of their weight-loss side effects, both drugmakers' sales have grown significantly

CagriSema has been shown to work for weight loss and lowering blood sugar in multiple clinical trials, indicating it could be a potential new treatment option for type 2 diabetes and weight management

, /, 1kg~5kg